Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastomaPaul M. Clément, Martin J. van den Bent, Marica Eoli et al.|European Journal of Cancer|2021Cited by 20